Insulin receptor activation in solitary fibrous tumours

Journal of Pathology

Volumn 211, Issue 5, 2007, Pages 550-554

  Li, Y ^a   Chang, Q ^a   Rubin, B P ^a   Fletcher, C D M ^a   Morgan, T W ^a   Metzer, S J ^a   Sugarbaker, D J ^a   Fletcher, J A ^a   Xiao, S ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

IGF 2; Insulin receptor; Solitary fibrous tumour

Indexed keywords

INSULIN RECEPTOR; SOMATOMEDIN B; SOMATOMEDIN C RECEPTOR;

ADULT; AGED; ARTICLE; AUTOCRINE EFFECT; BINDING AFFINITY; CANCER CELL CULTURE; CARCINOGENESIS; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; CULTURE MEDIUM; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOGLYCEMIA; MALE; PELVIS TUMOR; PLEURA TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; SIGNAL TRANSDUCTION; SOLITARY FIBROUS TUMOR;

ADULT; AGED; CULTURE MEDIA, SERUM-FREE; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR II; ISOMERISM; MALE; MIDDLE AGED; MITOGEN-ACTIVATED PROTEIN KINASES; NEOPLASM PROTEINS; NEOPLASMS, FIBROUS TISSUE; PHOSPHOPROTEINS; PLEURAL NEOPLASMS; RECEPTOR, IGF TYPE 1; RECEPTOR, INSULIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTION, GENETIC;

EID: 33947709940     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.2136     Document Type: Article

References (29)

1. Maune S, Gorogh T. [Detection of overexpression of insulin receptor gene in laryngeal carcinoma cells by using differential display method]. Laryngorhinootologie 2000;79:438-441.
2. Guillou L, Fletcher JA, Fletcher CDM, Mandahl N. Extrapleural solitary fibrous tumour and haemangiopericytoma. In World Health Organisation Classification of Tumours. Pathology and Genetics of Tumours of Soft Tissue and Bone, Fletcher CDM, Unni K, Mertens F (eds). IARC Press: Lyon, 2002; 86-90.
3. Le Roith D. Tumor-induced hypoglycemia [editorial; comment]. N Engl J Med 1999;341:757-758.
4. Le Roith D. Seminars in medicine of the Beth Israel Deaconess Medical Center. Insulin-like growth factors. N Engl J Med 1997;336:633-640.
5. Pagter-Holthuizen P, Hoppener JW, Jansen M, Geurts van Kessel AH, Van Ommen GJ, Sussenbach IS. Chromosomal localization and preliminary characterization of the human gene encoding insulin-like growth factor II. Hum Genet 1985;69:170-173.
6. Rotwein P, Folz RJ, Gordon JI. Biosynthesis of human insulin-like growth factor I (IGF-I). The primary translation product of IGF-I mRNA contains an unusual 48-amino acid signal peptide. J Biol Chem 1987;262:11807-11812.
7. Hwa V, Oh Y, Rosenfeld RG. The insulin-like growth factor-binding protein (IGFBP) superfamily. Endocr Rev 1999;20:761-787.
8. Baxter RC. Characterization of the acid-labile subunit of the growth hormone-dependent insulin-like growth factor binding protein complex. J Clin Endocrinol Metab 1999;67:265-272.
9. Kelley KM, Oh Y, Gargosky SE, Gucev Z, Matsumoto T, Hwa V, et al. Insulin-like growth factor-binding proteins (IGFBPs) and their regulatory dynamics. Int J Biochem Cell Biol 1996;28:619-637.
10. Daughaday WH, Emanuele MA, Brooks MH, Barbato AL, Kapadia M, Rotwein P. Synthesis and secretion of insulin-like growth factor II by a leiomyosarcoma with associated hypoglycemia. N Engl J Med 1988;319:1434-1440.
11. Daughaday WH, Kapadia M. Significance of abnormal serum binding of insulin-like growth factor II in the development of hypoglycemia in patients with non-islet-cell tumors. Proc Natl Acad Sci U S A 1989;86:6779-6782.
12. Ellis L, Tavare JM, Levine BA. Insulin receptor tyrosine kinase structure and function. Biochem Soc Trans 1991;19:426-432.
13. Morrione A, Valentinis B, Xu SQ, Yumet G, Louvi A, Efstratiadis A, et al. Insulin-like growth factor II stimulates cell proliferation through the insulin receptor. Proc Natl Acad Sci U S A 1997;94:3777-3782.
14. Pandini G, Vigneri R, Costantino A, Frasca F, Ippolito A, Fujita-Yamaguchi Y, et al. Insulin and insulin-like growth factor-I (IGF-I) receptor overexpression in breast cancers leads to insulin/IGF-I hybrid receptor overexpression: evidence for a second mechanism of IGF-I signaling. Clin Cancer Res 1999;5:1935-1944.
15. Fletcher JA, Kozakewich HP, Hoffer FA, Lage JM, Weidner N, Tepper R, et al. Diagnostic relevance of clonal cytogenetic aberrations in malignant soft-tissue tumors. N Engl J Med 1991;324:436-442.
16. Moller DE, Yokota A, Caro JF, Flier JS. Tissue-specific expression of two alternatively spliced insulin receptor mRNAs in man. Mol Endocrinol 1989;3:1263-1269.
17. Chang ED, Lee EH, Won YS, Kim JM, Suh KS, Kim BK. Malignant solitary fibrous tumor of the pleura causing recurrent hypoglycemia; immunohistochemical stain of insulin-like growth factor I receptor in three cases. J Korean Med Sci 2001;16:220-224.
18. She Q, Mukherjee JJ, Crilly KS, Kiss Z. Alpha(1)-antitrypsin can increase insulin-induced mitogenesis in various fibroblast and epithelial cell lines [in process citation]. FEBS Lett 2000;473:33-36.
19. Giorgino F, Belfiore A, Milazzo G, Costantino A, Maddux B, Whittaker J, et al. Overexpression of insulin receptors in fibroblast and ovary cells induces a ligand-mediated transformed phenotype. Mol Endocrinol 1991;5:452-459.
20. Frittitta L, Vigneri R, Stampfer MR, Goldfine ID. Insulin receptor overexpression in 184B5 human mammary epithelial cells induces a ligand-dependent transformed phenotype. J Cell Biochem 1995;57:666-669.
21. Spector SA, Olson ET, Gumbs AA, Friess H, Buchler MW, Seymour NE. Human insulin receptor and insulin signaling proteins in hepatic disease. J Surg Res 1999;83:32-35.
22. Kaplan GC, Pillion DJ, Rutter WJ, Kim H, Barker PE. Insulin receptor overexpression in a human pre-B acute lymphocytic leukemia cell line with a t(1;19) chromosome translocation near the INSR locus. Biochem Biophys Res Commun 1989;159:1275-1282.
23. Pandini G, Vigneri R, Costantino A, Frasca F, Ippolito A, Fujita-Yamaguchi Y, et al. Insulin and insulin-like growth factor-I (IGF-I) receptor overexpression in breast cancers leads to insulin/IGF-I hybrid receptor overexpression: evidence for a second mechanism of IGF-I signaling. Clin Cancer Res 1999;5:1935-1944.
24. Huang H, Potter CJ, Tao W, Li DM, Brogiolo W, Hafen E, et al. PTEN affects cell size, cell proliferation and apoptosis during Drosophila eye development. Development 1999;126:5365-5372.
25. Nakashima N, Sharma PM, Imamura T, Bookstein R, Olefsky JM. The tumor suppressor PTEN negatively regulates insulin signaling in 3T3-L1 adipocytes [in process citation]. J Biol Chem 2000;275:12889-12895.
26. Webster NJ, Resnik JL, Reichart DB, Strauss B, Haas M, Seely BL. Repression of the insulin receptor promoter by the tumor suppressor gene product p53: a possible mechanism for receptor overexpression in breast cancer. Cancer Res 1996;56:2781-2788.
27. Webster NJ, Kong Y, Sharma P, Haas M, Sukumar S, Seely BL. Differential effects of Wilms tumor WT1 splice variants on the insulin receptor promoter. Biochem Mol Med 1997;62:139-150.
28. Seely BL, Reichart DR, Takata Y, Yip C, Olefsky JM. A functional assessment of insulin/insulin-like growth factor-I hybrid receptors. Endocrinology 1995;136:1635-1641.
29. Johansson B, Billstrom R, Mauritzson N, Mitelman F. Trisomy 19 as the sole chromosomal anomaly in hematologic neoplasms. Cancer Genet Cytogenet 1994;74:62-65.